Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Equip Capital and Remagruppen in connection with the acquisition of Beredningsbart Syd
Mandate

Vinge advises Equip Capital and Remagruppen in connection with the acquisition of Beredningsbart Syd

October 23, 2023 Employment and Benefits M&A Real Estate and Construction

Vinge has advised the Norwegian private equity firm Equip Capital and its portfolio company Remagruppen in connection with the acquisition of Beredningsbart Syd AB (”BNB Syd”).

BNB Syd provides qualitative services within decontamination, demolition, recessing and waste management and conducts operations in southern Sweden. Remagruppen acquires and develops well-managed, stable and entrepreneur managed companies within the field of sustainable property maintenance.

Vinge’s team primarily consisted of Karl Klackenberg, Carl Fredrik Wachtmeister and Maximillian Bengtsson (M&A), Clara Klingspor (Construction), Olivia Onwuta (Employment) and Emma Emsjö (Project Assistant).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025